VIRX insider filings

Viracta Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-27. Screen VIRX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VIRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Viracta Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-11-274Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2024-11-274ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2024-09-124Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2024-09-124ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2024-06-244Borellini Flavia — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Chung Jane — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Murphy Samuel Lafayette — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244DARCY THOMAS E — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Simon Barry J. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Barlow Jane F — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Pomerantz Roger — DirectorGrant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 18,750 (derivative) @ $0EDGAR
2024-06-244Rubino Stephen — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244ROYSTON IVOR — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-294Pomerantz Roger — DirectorOption exercise (M): 9,035 @ $0 · Option exercise (M): 9,035 (derivative) @ $0EDGAR
2024-05-294ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2024-05-164Faerm Michael E. — Chief Financial OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2024-03-134Rothera Mark — President and CEO, DirectorGrant/award (A): 475,000 (derivative) @ $0EDGAR
2024-03-134Cohen Darrel P. — Chief Medical OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2024-03-134Chevallard Daniel R. — CFO and COOGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-02-274Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2024-02-274Chevallard Daniel R. — CFO and COOOption exercise (M): 6,889 @ $0 · Sale (S): 3,405 @ $0.73 · Option exercise (M): 6,889 (derivative) @ $0EDGAR
2024-02-274ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2023-12-044Rothera Mark — President and CEO, DirectorPurchase (P): 52,094 @ $0.49 · Purchase (P): 47,906 @ $0.49EDGAR
2023-11-284Chevallard Daniel R. — CFO and COOOption exercise (M): 6,889 @ $0 · Sale (S): 3,720 @ $0.50 · Option exercise (M): 6,889 (derivative) @ $0EDGAR
2023-11-284Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2023-11-284ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2023-08-294Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2023-08-294Chevallard Daniel R. — CFO and COOOption exercise (M): 6,888 @ $0 · Sale (S): 3,512 @ $1.45 · Option exercise (M): 6,888 (derivative) @ $0EDGAR
2023-08-294ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2023-08-184Pomerantz Roger — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2023-08-184Cohen Darrel P. — Chief Medical OfficerGrant/award (A): 235,000 (derivative) @ $0 · Grant/award (A): 265,000 (derivative) @ $0EDGAR
2023-06-094Simon Barry J. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Rubino Stephen — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Pomerantz Roger — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Murphy Samuel Lafayette — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094DARCY THOMAS E — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Chung Jane — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Borellini Flavia — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094Barlow Jane F — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-094ROYSTON IVOR — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-05-264Pomerantz Roger — DirectorOption exercise (M): 9,035 @ $0 · Option exercise (M): 9,035 (derivative) @ $0EDGAR
2023-05-264Chevallard Daniel R. — CFO and COOOption exercise (M): 6,889 @ $0 · Sale (S): 3,635 @ $1.42 · Option exercise (M): 6,889 (derivative) @ $0EDGAR
2023-05-264ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR
2023-03-174Rothera Mark — President and CEO, DirectorGrant/award (A): 400,000 (derivative) @ $0EDGAR
2023-03-174Rojkjaer Lisa — Chief Medical OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-03-174Chevallard Daniel R. — CFO and COOGrant/award (A): 200,000 (derivative) @ $0EDGAR
2023-02-284Rojkjaer Lisa — Chief Medical OfficerOption exercise (M): 4,127 @ $0 · Sale (S): 2,156 @ $1.68 · Option exercise (M): 4,127 (derivative) @ $0EDGAR
2023-02-284Pomerantz Roger — DirectorOption exercise (M): 9,034 @ $0 · Option exercise (M): 9,034 (derivative) @ $0EDGAR
2023-02-284Chevallard Daniel R. — CFO and COOOption exercise (M): 6,889 @ $0 · Sale (S): 3,599 @ $1.68 · Option exercise (M): 6,889 (derivative) @ $0EDGAR
2023-02-284ROYSTON IVOR — DirectorOption exercise (M): 25,219 @ $0 · Option exercise (M): 25,219 (derivative) @ $0EDGAR

Recent 8-K events — Viracta Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-02-058-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-318-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-01-248-K1.01 — Entry into a Material Definitive Agreement
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-12-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-11-298-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-228-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-068-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VIRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs